AIMC Topic: Drug Repositioning

Clear Filters Showing 81 to 90 of 270 articles

A deep learning-based drug repurposing screening and validation for anti-SARS-CoV-2 compounds by targeting the cell entry mechanism.

Biochemical and biophysical research communications
The recent outbreak of Corona Virus Disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been a severe threat to the global public health and economy, however, effective drugs to treat COVID-19 are still ...

Advancements in Drug Repurposing: Examples in Psychiatric Medications.

International journal of molecular sciences
Because there are a limited number of animal models for psychiatric diseases that can be extrapolated to humans, drug repurposing has been actively pursued. This study was aimed at uncovering recent trends in drug repurposing approaches and new techn...

DEDTI versus IEDTI: efficient and predictive models of drug-target interactions.

Scientific reports
Drug repurposing is an active area of research that aims to decrease the cost and time of drug development. Most of those efforts are primarily concerned with the prediction of drug-target interactions. Many evaluation models, from matrix factorizati...

Drug repurposing: Known knowns to unknown unknowns - Network analysis of the repurposome.

Drug discovery today
DrugRepurposing Online is a database of well-curated literature examples of drug repurposing, structured by reference to compounds and indications, via a generalisation layer (within specific datasets) of mechanism. References are categorised by leve...

Anti-Biofilm: Machine Learning Assisted Prediction of IC Activity of Chemicals Against Biofilms of Microbes Causing Antimicrobial Resistance and Implications in Drug Repurposing.

Journal of molecular biology
Biofilms are one of the leading causes of antibiotic resistance. It acts as a physical barrier against the human immune system and drugs. The use of anti-biofilm agents helps in tackling the menace of antibiotic resistance. The identification of effi...

DeepLPI: a novel deep learning-based model for protein-ligand interaction prediction for drug repurposing.

Scientific reports
The substantial cost of new drug research and development has consistently posed a huge burden for both pharmaceutical companies and patients. In order to lower the expenditure and development failure rate, repurposing existing and approved drugs by ...

Addressing Noise and Estimating Uncertainty in Biomedical Data through the Exploration of Chemical Space.

International journal of molecular sciences
Noise is a basic ingredient in data, since observed data are always contaminated by unwanted deviations, i.e., noise, which, in the case of overdetermined systems (with more data than model parameters), cause the corresponding linear system of equati...

Adera2.0: A Drug Repurposing Workflow for Neuroimmunological Investigations Using Neural Networks.

Molecules (Basel, Switzerland)
Drug repurposing in the context of neuroimmunological (NI) investigations is still in its primary stages. Drug repurposing is an important method that bypasses lengthy drug discovery procedures and focuses on discovering new usages for known medicati...

GCMM: graph convolution network based on multimodal attention mechanism for drug repurposing.

BMC bioinformatics
BACKGROUND: The main focus of in silico drug repurposing, which is a promising area for using artificial intelligence in drug discovery, is the prediction of drug-disease relationships. Although many computational models have been proposed recently, ...